Lasker Foundation Honors Seven, Presents New Award For First Time

SIDEBAR: For Further Reading 1996 LASKER LAUREATES: Seated, from left, are John Robbins and Rachel Schneerson; standing from left, are Ferid Murad, David Smith, Robert Furchgott, Paul Zamecnik, and Porter Anderson. The Albert and Mary Lasker Foundation entered its second half-century earlier this month by presenting a new prize along with its coveted medical research awards. For the first time in its 51-year history, the New York-based philanthropy bestowed the Albert Lasker Award for Special

| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

SIDEBAR: For Further Reading

The 1996 Albert Lasker Basic Medical Research Award was shared by Ferid Murad, 60, the former president and CEO of Molecular Geriatrics Corp. in Lake Bluff, Ill., and Robert F. Furchgott, 80, Distinguished Professor, Emeritus, at the State University of New York Health Science Center at Brooklyn. They were honored for their fundamental research on nitric oxide, now recognized as an important biochemical messenger.

Two teams shared the 1996 Albert Lasker Clinical Medical Research Award for their research in developing a vaccine against the bacterium Haemophilis influenzae type b (Hib). John B. Robbins, 64, chief of the laboratory of developmental and molecular immunity at the National Institute of Child Health and Human Development (NICHD) and Rachel Schneerson, 64, head of the section on bacterial disease in the NICHD laboratory of developmental and molecular immunity, were jointly honored with David H. Smith, 65, the president of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karen Young Kreeger

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo